SV1996000008A - Uso de amidas de acido fenilciclohexilcarboxilicos - Google Patents

Uso de amidas de acido fenilciclohexilcarboxilicos

Info

Publication number
SV1996000008A
SV1996000008A SV1996000008A SV1996000008A SV1996000008A SV 1996000008 A SV1996000008 A SV 1996000008A SV 1996000008 A SV1996000008 A SV 1996000008A SV 1996000008 A SV1996000008 A SV 1996000008A SV 1996000008 A SV1996000008 A SV 1996000008A
Authority
SV
El Salvador
Prior art keywords
fenilciclohexilcarboxilicos
amenas
acid
medicines
phenylciclohexyl
Prior art date
Application number
SV1996000008A
Other languages
English (en)
Inventor
Matthias Muller-Gliemann
Ulrich Muller
Martin Beauck
Siegfried Zaiss
Christoph Gerdes
Anke Domdey-Bette
Rudi Grutzmann
Stefan Lohmer
Stefan Wohlfeil
Ozkan Yalkinoglu
James Elting
Dirk Denzer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV1996000008A publication Critical patent/SV1996000008A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE RELACIONA CON AMIDAS DE ACIDOS FENILCICLOHEXILCARBOXILICOS, PARCIALMENTE CONOCIDAS, SON ADECUADAS COMO SUSTANCIAS ACTIVA EN MEDICAMENTOS, ESPECIALMENTE EN MEDICAMENTOS PARA EL TRATAMIENTO DE LA RESTENOSIS.
SV1996000008A 1995-02-01 1996-02-01 Uso de amidas de acido fenilciclohexilcarboxilicos SV1996000008A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503160A DE19503160A1 (de) 1995-02-01 1995-02-01 Verwendung von Phenylcyclohexylcarbonsäureamiden

Publications (1)

Publication Number Publication Date
SV1996000008A true SV1996000008A (es) 1996-11-04

Family

ID=7752849

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1996000008A SV1996000008A (es) 1995-02-01 1996-02-01 Uso de amidas de acido fenilciclohexilcarboxilicos

Country Status (31)

Country Link
US (1) US5935983A (es)
EP (1) EP0725064A1 (es)
JP (1) JPH08253453A (es)
KR (1) KR960031442A (es)
CN (1) CN1137380A (es)
AR (1) AR002272A1 (es)
AU (1) AU710235B2 (es)
BG (2) BG63044B1 (es)
CA (1) CA2168317A1 (es)
CZ (1) CZ29196A3 (es)
DE (1) DE19503160A1 (es)
DZ (1) DZ1986A1 (es)
EE (1) EE9600023A (es)
FI (1) FI960425A (es)
HR (1) HRP960017A2 (es)
HU (1) HUP9600227A3 (es)
IL (1) IL116931A (es)
MA (1) MA23794A1 (es)
NO (1) NO309841B1 (es)
NZ (1) NZ280905A (es)
PL (1) PL312546A1 (es)
RO (1) RO117256B1 (es)
RU (1) RU2158261C2 (es)
SG (1) SG42329A1 (es)
SK (1) SK13796A3 (es)
SV (1) SV1996000008A (es)
TN (1) TNSN96016A1 (es)
TW (1) TW448176B (es)
UA (1) UA35623C2 (es)
YU (1) YU5896A (es)
ZA (1) ZA96725B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE60221804T2 (de) * 2001-03-12 2008-05-15 Avanir Pharmaceuticals, San Diego Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US6934951B2 (en) 2002-01-17 2005-08-23 Intel Corporation Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
EP1651198A2 (en) * 2003-08-08 2006-05-03 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226109A1 (de) * 1992-08-07 1994-02-10 Bayer Ag Verwendung von ASS zur Hemmung von Plaquebildung
DE4304455A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe

Also Published As

Publication number Publication date
CZ29196A3 (en) 1996-08-14
DE19503160A1 (de) 1996-08-08
RO117256B1 (ro) 2001-12-28
CA2168317A1 (en) 1996-08-02
PL312546A1 (en) 1996-08-05
SG42329A1 (en) 1997-08-15
AR002272A1 (es) 1998-03-11
NO960414L (no) 1996-08-02
SK13796A3 (en) 1996-10-02
RU2158261C2 (ru) 2000-10-27
US5935983A (en) 1999-08-10
JPH08253453A (ja) 1996-10-01
YU5896A (sh) 1998-12-23
IL116931A (en) 2000-06-01
EE9600023A (et) 1996-08-15
UA35623C2 (uk) 2001-04-16
ZA96725B (en) 1996-08-20
IL116931A0 (en) 1996-05-14
TW448176B (en) 2001-08-01
HUP9600227A2 (en) 1996-12-30
EP0725064A1 (de) 1996-08-07
AU710235B2 (en) 1999-09-16
MA23794A1 (fr) 1996-10-01
HU9600227D0 (en) 1996-03-28
FI960425A (fi) 1996-08-02
BG100326A (bg) 1996-08-30
TNSN96016A1 (fr) 2005-03-15
BG63044B1 (bg) 2001-02-28
BG103820A (bg) 2001-09-28
AU4224096A (en) 1996-08-08
HRP960017A2 (en) 1997-12-31
NO309841B1 (no) 2001-04-09
CN1137380A (zh) 1996-12-11
KR960031442A (ko) 1996-09-17
HUP9600227A3 (en) 2000-03-28
NZ280905A (en) 1996-12-20
NO960414D0 (no) 1996-01-31
DZ1986A1 (fr) 2002-10-15
FI960425A0 (fi) 1996-01-30

Similar Documents

Publication Publication Date Title
ES2170884T3 (es) Acidos alfa-iminohidroxamicos y carboxilicos n-sustituidos, ciclicos y heterociclicos.
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
ES2147320T3 (es) Derivados de n-(3-benzofuranil)urea.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
EP1143950A3 (de) Topisch anwendbare mittel
SV1996000026A (es) Benzociclopentano oxazolidinonas que contienen heteroatomos
ZA96503B (en) Stable-lipid-comprising drug delivery complexes and methods for their production
BR9709823A (pt) Amidas de piridil alqueno-e priridil alquino-ácido como citostáticos e imuno-supressores
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
SV1996000008A (es) Uso de amidas de acido fenilciclohexilcarboxilicos
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ES2184844T3 (es) Procedimiento mejorado de sintesis de n-(3-(3-cianopirazolo(1,5-a)pirimidin-7-il)fenil)n-etilacetasmida.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
DE69712900T2 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DE69510928D1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
ES2164434T3 (es) Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8.
ES2150705T3 (es) Derivados de ester de nitrito esteroideos utiles como farmacos antiinflamatorios.
ES2150021T3 (es) Derivados de acidos piridin- y pirazin-dicarboxilicos como reguladores de la proliferacion celular.
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
AR021694A1 (es) Retinamidas de acido 7-aril-6-(z)heptatrienoico
ES2148600T3 (es) Derivados de indol sustituidos.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.